Cargando…

Time to define common European criteria for therapeutic added value

Detalles Bibliográficos
Autores principales:	Boucaud-Maitre, Denis, Salvo, Francesco, Berdaï, Driss
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102085/ https://www.ncbi.nlm.nih.gov/pubmed/33966855 http://dx.doi.org/10.1016/j.therap.2021.04.011

Ejemplares similares

Post-containment management of nursing homes: a new public health concern
por: Boucaud-Maitre, Denis, et al.
Publicado: (2020)

Defining the criteria for identifying constitutional epimutations
por: Sloane, Mathew A., et al.
Publicado: (2016)

Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control
por: de Carvalho-Pinto, Regina Maria, et al.
Publicado: (2017)

How to Define an Author? Awareness of Authorship Criteria
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2013)

The potential added value of FDG PET/CT for COVID-19 pneumonia
por: Deng, Yan, et al.
Publicado: (2020)

The Network for Evaluation of One Health: evidence-based added value of One Health
por: Haxton, Eva, et al.
Publicado: (2015)

Rationale for Change in the Criteria for Defining Severe Ischemic Mitral Regurgitation in 2017 American College of Cardiology/American Heart Association Guidelines
por: Jose, Reshmi Liza, et al.
Publicado: (2018)

“Stay at home”. Home dialysis, an added benefit in times of pandemic()
por: Slon Roblero, Maria Fernanda, et al.
Publicado: (2021)

No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients
por: Volff, Maxime, et al.
Publicado: (2020)

On the authorship criteria
por: Rakhshan, Vahid
Publicado: (2014)

Defining sarcopenia and myosteatosis: the necessity for consensus on a technical standard and standardized cut‐off values
por: Westenberg, Lisa B., et al.
Publicado: (2022)

Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
por: Vassiliou, V, et al.
Publicado: (2010)

Reply: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
por: Hamaoka, T, et al.
Publicado: (2010)

What is the added value of the waist‐to‐hip ratio on top of the BIOSTAT risk prediction model in patients with heart failure? Reply
por: Streng, Koen W., et al.
Publicado: (2018)

The Maze of Vasodilator Response Criteria
por: Douwes, J. Menno, et al.
Publicado: (2010)

Plagiarism: Intention and diagnostic criteria
por: Shashok, Karen
Publicado: (2012)

Sepsis: Mr. Machado's criteria
por: Gomes, José Andrade
Publicado: (2017)

Assessment of the therapeutic value of new medicines marketed in Australia
por: Wonder, Michael J
Publicado: (2013)

Standardized PaO(2)/FiO(2) ratio in COVID-19: Added value or risky assumption. Author's reply
por: Prediletto, Irene, et al.
Publicado: (2022)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

Long time blood-transfusion trend in a European general hospital
por: Enko, Dietmar, et al.
Publicado: (2020)

Problems in the Japanese criteria for metabolic syndrome
por: Oda, Eiji
Publicado: (2011)

Reproducibility of Diagnostic Criteria for Ventricular Neurocysticercosis
por: Fleury, Agnes, et al.
Publicado: (2017)

Is it time to revisit the PaO(2)/FiO(2) ratio to define the severity of oxygenation in ARDS?
por: Palanidurai, Sunitha, et al.
Publicado: (2021)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?: Author's Reply
por: Park, Dong Won, et al.
Publicado: (2010)

Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2018: Revision of Japanese Clinical Diagnostic Criteria for Autoimmune Pancreatitis, 2011
por: Kawa, Shigeyuki, et al.
Publicado: (2020)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

Meta-analysis: Adding apples and oranges?
por: Ranganathan, Priya
Publicado: (2014)

REGIONAL DIFFERENCES IN THE CONCEPT AND THERAPEUTIC VALUE OF YOGA - AN E-MAIL SURVEY
por: Pandey, Ravi S., et al.
Publicado: (2000)

Are the Number of Operations Appropriate to Define a High-Quality Breast Cancer Center?
por: Tralongo, Paolo, et al.
Publicado: (2023)

Myocarditis following rAd26 and rAd5 vector‐based COVID‐19 vaccine: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Sensing Change: On Adding a Psychological Touch of Grit to Conventional Medical School Selection Criteria [Letter]
por: Rizvi, Syeda Zoha Zehra, et al.
Publicado: (2020)

Defining success in graduate school
por: Bell, Sean M., et al.
Publicado: (2014)

TTR: Time in Therapeutic Range or “The Troublesome Report”?
por: Reiffel, James A.
Publicado: (2019)

Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria
por: Coccina, Francesca, et al.
Publicado: (2020)

Diagnostic Criteria during SARS Outbreak in Hong Kong
por: Chan, Louis Y., et al.
Publicado: (2004)

Redefining expanded criteria donor kidneys in the developing world
por: Khan, Taqi T., et al.
Publicado: (2013)

Diagnostic criteria for drug rash and eosinophilia with systemic symptoms
por: Pannu, Ashok Kumar, et al.
Publicado: (2017)

Scoring criteria for the evaluation of micronuclei in oral exfoliated cells
por: Grover, Sonal, et al.
Publicado: (2017)

Proposal on the Diagnostic Criteria of Definite Isolated Otolith Dysfunction
por: De Chua, Kenneth Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6pmgs7nflkatasldgtd5n4bk9f